LOGIN  |  REGISTER
Chimerix

Recent Insider Transactions - Corvus Pharmaceuticals (NASDAQ: CRVS)

Follow NASDAQ:CRVS Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ CRVS Corvus Pharmaceuticals
ORBIMED ADVISORS LLC / director, 10 percent owner:
06/27/2025
Buy
$3.50
1.40M
$4.892M
8.34M
NASDAQ CRVS Corvus Pharmaceuticals
ORBIMED ADVISORS LLC / director, 10 percent owner:
06/27/2025
Sell
$4.16
1.18M
$4.892M
7.17M
NASDAQ CRVS Corvus Pharmaceuticals
ORBIMED ADVISORS LLC / director, 10 percent owner:
06/27/2025
Sell
$3.50
1.40M
$4.892M
0
NASDAQ CRVS Corvus Pharmaceuticals
Thompson Peter A. / director, 10 percent owner:
06/27/2025
Buy
$3.50
1.40M
$4.892M
8.34M
NASDAQ CRVS Corvus Pharmaceuticals
Thompson Peter A. / director, 10 percent owner:
06/27/2025
Sell
$4.16
1.18M
$4.892M
7.17M
NASDAQ CRVS Corvus Pharmaceuticals
Thompson Peter A. / director, 10 percent owner:
06/27/2025
Sell
$3.50
1.40M
$4.892M
0
NASDAQ CRVS Corvus Pharmaceuticals
Grais Linda / director
06/12/2025
Buy
$4.24
15,000
$64K
15,000
NASDAQ CRVS Corvus Pharmaceuticals
CLARK IAN T / director
06/12/2025
Buy
$4.24
15,000
$64K
15,000
NASDAQ CRVS Corvus Pharmaceuticals
Morrison Scott W / director
06/12/2025
Buy
$4.24
15,000
$64K
15,000
NASDAQ CRVS Corvus Pharmaceuticals
Thompson Peter A. / director, 10 percent owner:
06/12/2025
Buy
$4.24
15,000
$64K
15,000
NASDAQ CRVS Corvus Pharmaceuticals
Jones William Benton / officer: See Remarks
06/04/2025
Buy
$3.50
19,357
$68K
173,130
NASDAQ CRVS Corvus Pharmaceuticals
Jones William Benton / officer: See Remarks
06/04/2025
Sell
$3.50
19,357
$68K
0
NASDAQ CRVS Corvus Pharmaceuticals
MILLER RICHARD A MD / director, officer: President and CEO
05/07/2025
Buy
$3.50
559,073
$1.957M
1.14M
NASDAQ CRVS Corvus Pharmaceuticals
MILLER RICHARD A MD / director, officer: President and CEO
05/07/2025
Sell
$3.50
559,073
$1.957M
0

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous